Stargardt Disease Clinical Trials in Pittsburgh, Pennsylvania

3 studies are recruiting for stargardt disease in Pittsburgh, Pennsylvania right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. Study of ALK-001 on the Progression of Stargardt Disease

    This study evaluates the efficacy and safety of investigational study drug ALK-001 in participants 8 to 45 years of age, inclusive, with symptoms and signs of autosomal recessive Stargardt disease (STGD)

    Stage
    Phase 3
    Ages
    8 to 45
    Site
    UPMC Vision Institute, Pittsburgh, Pennsylvania
    Locations
    14 in total
    Run by
    Alkeus Pharmaceuticals, Inc.

    See if you can join NCT07419334 on ClinicalTrials.gov

  2. A Study to Learn How Stargardt-type Eye Conditions Progress in Children and Adults

    Macular dystrophies are a group of inherited eye conditions that affect the macula. The macula is in the center of the retina, the light sensitive part at the back of the eye. In people with macular dystrophies, some of the cells in the macula gradually stop working and may die over time. This lead…

    Stage
    Not phased
    Ages
    6 and older
    Site
    University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania
    Locations
    15 in total
    Run by
    Astellas Pharma Global Development, Inc.

    See if you can join NCT07425574 on ClinicalTrials.gov

  3. Phase 1/2 Open-Label Dose-Escalation Study to Evaluate Safety of a Single Intravitreal Injection of RTx-021 in Patients With Stargardt Disease

    A Phase 1/2, open-label, non-randomized, dose-escalation study, where a minimum of 9 and a maximum of 18 eligible patients with Stargardt Disease will be enrolled sequentially in up to 3 dose cohorts of RTx-021. Enrolled patients will receive a single, unilateral intravitreal injection of RTx-021 i…

    Stage
    Phase 1
    Ages
    16 and older
    Site
    UPMC Vision Institute, Pittsburgh, Pennsylvania
    Locations
    3 in total
    Run by
    Ray Therapeutics, Inc.

    See if you can join NCT07439887 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.